Speakers - International Society of Microbiota

12th World Congress on Targeting Microbiota 2025

Only Uncategorised
Number of Downloads: 2	Order Files by: Default \| Name \| Author \| Date \| Hits

Files:

Programme 2021 4 HOT

(0 votes)

Download

Created
Size
Downloads

2018-07-16
1.36 MB
6,989.00

Congress Flyer HOT

(0 votes)

Download

Created
Size
Downloads

2018-08-29
700.65 KB
4,872.00

Back

Powered by jDownloads

News

Dr. Carmelo Scarpignato Wins ISM Best Scientific Contribution 2024 for Research on Drug Effects and Gut Microbiota

We are pleased to announce that Dr. Carmelo Scarpignato, United Campus of Malta & Chines...

Bac3Gel Win Targeting Microbiota 2024 Best Short Oral Presentation (1)

Congratulations to Victoria Navas from Bac3Gel, Portugal, for winning the Best Short Oral Present...

ISM Best Short Oral 2024 (2): Impact of Radio-Chemotherapy on Intestinal Dysbiosis in Cervical Cancer Patients

Congratulations to Ksenia Klimov-Kravtchenko and her team from the University of Guadalajara, Mex...

ISM Best Poster 2024 (2): Indoxyl Sulfate's Role in Dyslipidemia and Cholesterol Gene Expression

We are pleased to announce that Mateusz Szudzik from the Medical University of Warsaw, Poland, has won the Best Poster Presen...

ISM Best Poster 2024 (1): Exploring the Mycobiome in Autism Spectrum Disorder

Congratulations to Vlasta Demeckova and her team from Pavol Jozef Safarik University and the University of Ve...

Drug Effects of Gut Microbiota in Humans: Clinical Consequences

It is a great pleasure to welcome Prof. Carmelo Scarpignato, Chinese University of Hong Kong, China, to Targeting Microb...

Phage Therapy: A New Era of “Old” Concept for “Microbiome” Health

Dr. Mzia Kutateladze, Eliava Institute of Bacteriophage, Georgia, will join Targeting Microbiota 2024 this October will share...

Does the Microbiome Control Cravings and Addictive Behavior of their Host: A New Prospective and Hope for Treating Addiction

It is a great pleasure to welcome Dr. Steven R. Gundry, Medical Director at The Centers for Restorative Medicine, USA,&n...

Culturing the Complexity of Intestinal Microbiota In-Vitro in Bac3Gel®

Dr. Daniela Pacheco, CTO and Founder of Bac3Gel, Portugal, will share her latest research during Targeting Microbiota 2024 th...

Using Roseoflavin, a Natural Riboflavin Analogue, to Modify the Human Microbiota

The ISM is pleased to welcome Prof. Markus Egert, active member of the ISM scientific board, from Furtwangen University...

Prospects for Leveraging the Microbiota as Medicine for Hypertension

The ISM is pleased to announce that Dr. Bina Joe, Eidtor-in-Chief of Microbiota and Host, from the University of Toledo, USA...

Gut Microbiome, Obesity and Diabetes

Prof. Hiroshi Ohno, RIKEN Center for Integrative Medical Sciences, Japan, will join Targeting Microbiota 2024 this October to...

Gut Brain Axis & Depression: Startegic Role of Dietary Proline Exposed

The ISM is pleased to welcome Prof. José Manuel Fernández-Real, Universitat de Girona, Spain join Targeting Microbi...

Mythbusting Our Microbiome

Prof. Alan Walker, University of Aberdeen, United Kindgom, will join Targeting Microbiota 2024 this October to give a present...

From Microbiomes and (Meta)genomes to the Lab and Back - Identification, Production and Application of Bacteriocins

The ISM is pleased to announce that Dr. Christian Riedel, University of Ulm, Germany, will be speaking at Targeting Microbiot...

Deciphering the role of the Oral-Placental and Vaginal-Placental Microbiome Axes in Preterm Birth

The ISM is pleased to announce that Dr. Souhaila Al Khodor, Sidra Medicine, Qatar, will be speaking at Targeting Microbiota 2...

Gut Microbiota in Early Life: Impact on Neurodevelopmental Outcomes

Dr. Rochellys Diaz Heijtz, Karolinska Institutet, Sweden, will share her latest research during Targeting Microbiota 2024 thi...

Male Fertility and Gut Microbiota: Current Knowledge and Future Directions

Prof. Cristian O'Flaherty from McGill University, Canada, will join Targeting Microbiota 2024 this October to present his lat...

The Small Intestinal Microbiota: A Hidden Player in Human Health and Disease

The ISM is excited to announce that Dr. Pascale Vonaesch from the University of Lausanne, Switzerland, will be speaking at Ta...

Bacteriophages Redesigned – Tiny Killers and Detectives to Support Infectious Disease Therapy

Dr. Martin Loessner, ETH Zurich, Switzerland, will share his latest research during Targeting Microbiota 2024 this October. ...

Microbial Phenotypes in Obesity: Implications for Precision Nutrition

The ISM is pleased to welcome Prof. Ellen Blaak, Maastricht University, Netherlands join Targeting Microbiota 2024 ...

Probiotics & Health: How to Select the Right Strain?

Prof. Andreas Schwiertz, from the Institute of Microecology and member of the ISM scientific board, Germany, will join Target...

Sophisticated in vitro Models of the Gastrointestinal Tract to Study the Role of the Gut Microbiota in Health and Disease

Dr. Koen Venema, Editor-in-chief of Beneficial Microbes from The Netherlands, will join Targeting Microbiota 2024 this Octobe...

The Mystery of the Microbiome Genome: The Potential of 2 to 20 Million Microbial Genes to Transform Our Health

Prof. Marvin Edeas, chairman of the ISM Scientific Board from Institut Cochin, INSERM U1016, Université de Paris, France will...

1
2
3

News Archives

Microbiota in the Press & Media

Mitochondrial Dysfunction Disrupts Microbiome, Leading to Crohn’s Disease

Identification of Distinct Stool Metabolites in Women with Endometriosis for Non-Invasive Diagnosis and Microbiota-Based Therapeutic Potential

Significant Dysregulation in Aging Markers at 44 and 60 Years Revealed by Nonlinear Analysis

Protein Pacing with Intermittent Fasting Enhances Gut Microbiome and Metabolomic Profile Compared to Continuous Caloric Restriction

Optimizing Garvicin Q Bacteriocin Production Using Corynebacterium glutamicum

1
2
3

Prev Next

Read more News

Skip to content

ISM Congress 2024

ISM

ISM Congress 2023

Follow Us

News

Microbiota in the Press & Media